Sifrol ER

Sifrol ER Warnings

pramipexole

Manufacturer:

Boehringer Ingelheim

Distributor:

DKSH
Full Prescribing Info
Warnings
Sudden onset of sleep during daily activities has been reported in rare cases. This can be life-threatening to the patient or others depending on the circumstances. These episodes have been reported in some cases without awareness of warning signs. If this occurs, reduction of dosage or termination of therapy should be considered. Patients being treated with pramipexole must be informed not to drive or engage in other activities where impaired alertness could put themselves or others at risk of serious injury or death (e.g. operating machines). Because of possible additive effects, caution should be advised when patients are taking other sedating medication or alcohol in combination with pramipexole (see Driving and using machines under Precautions and Adverse Reactions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in